As declared by the World Health Organization (WHO), antimicrobial resistance (AMR) is one of the top ten global public health threats facing humanity in the coming decade. Importantly, there is a growing global concern about the rapid increase of AMR while the development of new antimicrobials is on steady decline. Therefore, the aim of our research group is to highlight new advances in understanding of antimicrobial resistance mechanisms at the molecular level as well as the epidemiology and distribution of antimicrobial resistance patterns. The long-term goal of the lab is to develop novel diagnostics and treatment options including antimicrobials using advance technology.